uses cookies to improve your experience on the site. Your continued use of the site constitutes your acceptance of use of cookies on this site.
Find out more about how SonoWorld uses cookies. I’m OK with Cookies from SonoWorld - stop showing me this banner.
189,067 Registered Members as of 10/19/2021.
David Cosgrove, MD
EFSUMB Guidelines and Recommendations on CEUS
David Cosgrove, MD
12/25/2016 | Time : 22 min
About This Lecture:

The speaker discusses the use of contrast agents in liver lesion detection and characterization. Upon completion of this educational activity the participant will recognize the role that CEUS plays in the detection and characterization of liver lesions, as well as adverse events that may occur with contrast agent use.

Topics mentioned in this video : Focal liver lesions: characterization, Focal liver lesions: detection, Adverse events, LI-RADS

To view this lecture video, Login or register for a free membership below ↓
Already a Member? Login
Forgot username or password?
Register for Your FREE Membership Now!
Sign Up In Less Than One Minute
  • UNLOCK access to SonoWorld lectures, articles, cases, and more
  • Full Access Membership is FREE
  • You will have IMMEDIATE access on submitting the Membership form
  • JOIN the world's largest community of ultrasound professionals

* *
* *
* *
Review the SonoWorld Privacy Policy here.
Weekly Update Newsletter :
New Products and Services :
        Terms & Conditions         Privacy Policy

Keywords : CEUS, cholangiocarcinoma, cirrhotic liver, contrast enhanced ultrasound, contrast wash in, contrast wash out, EFSUMB, European Federation of Societies for Ultrasound in Medicine and Biology, FNH, focal fatty change, focal nodular hyperplasia, HCC, heaptocellular carcinoma, LI-RADS, liver adenoma, liver cyst, liver hemangioma, Liver Imaging Reporting and Data System, liver met, metastatic liver lesion

IE Browser Compatibility Close